| Business Name: | Bind Therapeutics |
| Categorized In: | Noncommercial Biotechnical Research |
| Address: | 325 Vassar St, Cambridge, MA 02139 |
| Phone Number: | (617) 491-3400 |
| Contact Person: | Scott Minick, Chief Executive Officer |
| Website Address: | bindtherapeutics.com |
| NAICS Code: | 4461100 |
| SIC Code: | 8733 |
| Business Type: | B2B (Business to Business) |
| Founding Year: | 2006 |
| Employee #: | 1 to 4 |
| Location Type: | Single Location |
| Annual Revenue ($): | $5.000.000 to $9.999.999 |
| Share This Business: | |
| Similar Businesses: |
Transkaryotic Therapies Inc - Cambridge, MA 02139 Massachusetts Institute Of Technology - Cambridge, MA 02139 Genewiz - Cambridge, MA 02139 |
Bind Therapeutics provides professional Noncommercial Biotechnical Research from its single location at the coordinates 42.35488,-71.1056.
The company offers B2B variables under the SIC code 8733 and NAICS code 4461100, while making an annual revenue of $5.000.000 to $9.999.999 and hiring a total of 1 to 4 employees.
Founded in 2006, the company can now be visited at 325 Vassar St, Cambridge, Massachusetts 02139 or contacted through representative Scott Minick, Chief Executive Officer at (617) 491-3400.
For frequently asked questions and further inquiries about professional Noncommercial Biotechnical Research, get to know more about Bind Therapeutics through its company website at bindtherapeutics.com. Engage with this business on its social media platforms through on Twitter and on Facebook.